Articles tagged "COVID-19"

2022 American Transplant Congress
Successful Kidney Transplantation from a Deceased Donor with Severe COVID-19: Undetectable SARS-CoV-2 in Donor Kidney and Aorta by Sensitive Molecular Testing
K. Lee¹, N. M. Desai¹, J. Resnick², M. Li², A. Johanson¹, A. Pekosz², H. Rabb¹, J. L. Mankowski¹
¹Johns Hopkins University School of Medicine, Baltimore, MD, ²Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
*Purpose: Kidney transplantation (KT) from coronavirus disease 2019 (COVID-19) positive donors has been avoided due to concerns for donor-derived transmission and possibility of the kidney…
2022 American Transplant Congress
Serological Response To Three, Four And Five Doses Of Sars-cov-2 Vaccine In Kidney Transplant Recipients
S. Ronicke¹, B. Osmanodja¹, K. Budde¹, A. Jens¹, C. Hammett¹, K. Nadine¹, J. Waiser¹, B. Zukunft¹, F. Bachmann¹, M. Choi¹, W. Ulrike¹, B. Eberspächer², J. Hofmann², F. Grunow¹, M. Mikhailov¹, L. Liefeldt¹, K. Eckardt¹, F. Halleck¹, E. Schrezenmeier¹
¹Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Berlin, Germany, ²Labor Berlin - Charité Vivantes GmbH, Berlin, Germany
*Purpose: Mortality from COVID-19 among kidney transplant recipients (KTR) is unacceptably high, and their response to up to three vaccinations against SARS-CoV-2 is strongly impaired.…
2022 American Transplant Congress
Post-Acute Sequelae of Sars-Cov-2 Infection in Solid Organ Transplant Recipients
S. Alasfar¹, T. Chiang¹, A. J. Snyder², M. T. Ou¹, B. Boyarsky¹, A. T. Abedon¹, J. L. Alejo¹, W. Cochran¹, J. M. Garonzik-Wang³, D. C. Brennan¹, T. Vannorsdall¹, D. L. Segev¹, R. K. Avery¹
¹Johns Hopkins University, Baltimore, MD, ²University of Washington, Seattle, WA, ³University of Wisconsin, Madison, WI
*Purpose: Post-acute sequelae of SARS-CoV-2 infection (PASC) is an increasingly recognized phenomenon manifested by long lasting cognitive, mental, and physical symptoms. We aimed to estimate…
2022 American Transplant Congress
Sars-cov-2 Antibodies Transitions After Vaccination In Solid Organ Transplant Recipients: Multicenter Study In Japan
K. Unagami¹, M. Yoshikawa², Y. Natori³, K. Omoto¹, H. Ishida¹, H. Date⁴, R. Imamura⁵, T. Ito⁴, K. Miyaji⁶, S. Takahara⁷, K. Yuzawa⁸, O. Satoko⁹, Y. Hirota¹⁰, H. Egawa¹
¹Tokyo Women's Medical University, Tokyo, Japan, ²Kyoto Prefectural University of Medicine, Kyoto, Japan, ³University of Miami, Pinecrest, FL, ⁴Kyoto University, Kyoto, Japan, ⁵Dept. of Urology, Osaka Univ. Graduate School of Medicine, Suita, Japan, ⁶Renal Transplantation, Takatsuki General Hospital, Takatsuki, Japan, ⁷Kansai Medical Hospital, Toyonaka, Japan, ⁸Tranplantation Surgery, National Hospital Organization Mito Medical Center, Mito, Japan, ⁹Public Health, Osaka City University Graduate School of Medicine and Research Center for Infectious, Osaka City University Graduate School of Medicine, Osaka, Japan, ¹⁰Clinical Epidemiology Research Center, Miyama, Japan
*Purpose: For purpose of SARS-CoV-2 infection control, vaccination was started in worldwide, however, low reactivity of antibody production after vaccination is a concern for solid…
2022 American Transplant Congress
Decreased Mortality from Sars-CoV-2 Infection in Kidney Transplant Recipients Over the Course of the Pandemic
Y. Al Azzi, P. Loarte, C. Pynadath, L. Liriano, M. Ajaimy, S. Kapoor, H. Yaffe, M. Le, J. Graham, J. Rocca, S. Greenstein, M. Kinkhabwala, E. Akalin
Montefiore Medical Center, Bronx, NY
*Purpose: We aimed to investigate the mortality from SARS-CoV-2 in kidney transplant recipients in the Bronx, New York since the beginning of the pandemic*Methods: Between…
2022 American Transplant Congress
Kidney Transplantation from Deceased Donors with Vaccine-Induced Thrombosis and Thrombocytopenia: An Updated Analysis of the UK Experience
G. Greenhall, ,. UK VITT Donor Kidney Transplant Study Group
NHS Blood and Transplant, Bristol, United Kingdom
*Purpose: Vaccine-induced thrombosis and thrombocytopenia (VITT) is a rare syndrome that has emerged since widespread vaccination against SARS-CoV-2. As a result of the high mortality,…
2022 American Transplant Congress
The Effect of COVID-19 Pandemic in Intestinal Rehabilitation and Transplant Patients – International Multicenter Survey
M. Segovia¹, M. Fernandez², S. Jafri³, T. Schiano⁴, S. Horslen⁵, C. Rumbo², C. Zanfi⁶, A. Testro⁷, L. Sharkey⁸, F. Braun⁹, H. Vilca Melendez¹⁰, R. Sanchez Claria¹¹, L. Ceulemans¹², T. Hibi¹³, D. Ramish², G. Noel¹, G. Dijkstra¹⁴, P. Friend¹⁵, F. Lacaille¹⁶, D. Sudan¹, G. Mazariegos¹⁷, J. Yap¹⁸, G. Herlenius¹⁹, H. Solar², G. Gondolesi²
¹Duke, Durham, NC, ²Favaloro, Buenos Aires, Argentina, ³Henry Ford, Detroit, MI, ⁴Mount Sinai, New York, NY, ⁵UPMC, Edgeworth, PA, ⁶U Bologna, Bologna, Italy, ⁷Austin Health, Melbourne, Australia, ⁸Cambridge, Cambridge, United Kingdom, ⁹Schleswig-Holstein, Kiel, Germany, ¹⁰King's College, London, United Kingdom, ¹¹Hosp Italiano, Buenos Aires, Argentina, ¹²U Leuven, Brussels, Belgium, ¹³Kumamoto Univ, Kumamoto, Japan, ¹⁴U Groningen, Groningen, Netherlands, ¹⁵U Oxford, Oxford, United Kingdom, ¹⁶Necker-Enfants Malades, Paris, France, ¹⁷UPMC, Pittsburgh, PA, ¹⁸U Melbourne, Melbourne, Australia, ¹⁹U Sahlgrenska, Gothenburg, Sweden
*Purpose: It has been proposed that patients with intestinal failure (IF) and intestine transplant (IT) are at higher risk of severe complications of COVID-19 due…
2022 American Transplant Congress
Evolution of Cellular and Humoral Immunity During and After a Three Doses-Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients
D. Cucchiari¹, N. Egri¹, J. Casals-Urquiza², J. Del Risco-Zevallos¹, D. Rodríguez-Espinosa³, E. Montagud-Marrahi², J. Rovira⁴, M. Ramirez-Bajo⁵, E. Banón-Maneus⁵, P. Ventura-Aguiar², M. Pascal¹, I. Revuelta⁶, B. Bayès², F. Diekmann²
¹Hospital Clínic de Barcelona, Barcelona, Spain, ²Hospital Clinic de Barcelona, Barcelona, Spain, ³Nephrology and Renal Transplantation, Hospital Clinic of Barcelona, Barcelona, Spain, ⁴Laboratori Experimental de Nefrologia i Trasplantament (LENIT), IDIBAPS, Barcelona, Spain, ⁵IDIBAPS, Barcelona, Spain, ⁶Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain
*Purpose: Seroconversion after a 2 doses of mRNA COVID-19 vaccine in kidney transplant recipients (KTR) ranges between 30 and 50% in different series. We previously…
2022 American Transplant Congress
Pre-Transplant Vaccine Induced SARS-CoV-2 Antibodies Decrease Following Induction Therapy for Kidney Transplantation
N. Barros¹, A. C. Ermel¹, A. Sharfuddin², W. Goggins³, J. Fridell²
¹Indiana University, Indianapolis, IN, ²Indiana University School of Medicine, Indianapolis, IN, ³Indiana University Hospital, Indianapolis, IN
*Purpose: Kidney transplant recipients (KT) and wait-listed individuals exhibit an impaired response to vaccinations. There is currently no data on the impact of induction immunosuppression…
2022 American Transplant Congress
Adverse Renal Events After BNT162b2 Pfizer/BioNTech COVID-19 Vaccine in Kidney Transplant Recipients
H. K. Sran¹, E. Wong¹, M. R. D'Costa², A. Lim², Q. Lim², A. Vathsala¹
¹National University of Singapore, Singapore, Singapore, ²National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore
*Purpose: Adverse events of a novel mRNA vaccine are not well described in Kidney Transplant Recipients(KTR), especially the risk of immune activation or recurrent glomerulonephritis(GN),…